Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04506151 · ClinicalTrials.gov registry record · NA

Sleep Optimization to Improve Glycemic Control in Adults With Type 1 Diabetes

A NA study of Type 1 Diabetes, sponsored by University of Illinois at Chicago.

Active
Registry status
NA
Development phase
144
Enrollment target
1
Study location

NCT04506151 is a NA study of Type 1 Diabetes that is active but no longer recruiting, run by University of Illinois at Chicago. The registered enrollment target is 144 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04506151, a NA study of Type 1 Diabetes, is active but no longer recruiting, sponsored by University of Illinois at Chicago.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
144 participants
Enrollment target
1
Study location

Study Summary

Up to 40% of adults with type 1 diabetes have insufficient sleep which is associated with negative health consequences including poor blood glucose control and greater diabetes complications. In this study, a sleep intervention (Sleep-Opt) that uses wearable sleep tracking technology, telephone coaching and informational content designed to improve sleep and glycemic control in working-age adults with type 1 diabetes. Sleep-Opt could lead to reduced development of diabetes complications and improve quality of life for adults with type 1 diabetes.

Conditions Studied

Interventions

  • BEHAVIORAL Healthy Living
  • BEHAVIORAL Sleep-Opt

Study Locations (1)

Illinois

  • University of Illinois Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 144 participants
Start Date 2021-01-19
Est. Completion 2026-04-30
Phase NA

Sponsor

University of Illinois at Chicago

430 total trials

What the Registry Record Tells You About NCT04506151

The ClinicalTrials.gov registry entry for NCT04506151 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (83% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Healthy Living is the first listed.

NCT04506151 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04506151 about?

NCT04506151 is a clinical study titled "Sleep Optimization to Improve Glycemic Control in Adults With Type 1 Diabetes". Up to 40% of adults with type 1 diabetes have insufficient sleep which is associated with negative health consequences including poor blood glucose control and greater diabetes complications. In this study, a sleep intervention (Sleep-Opt) that uses wearable sleep tracking technology, telephone coac...

What is the current status of trial NCT04506151?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 144 participants. The study started on 2021-01-19. Estimated completion is 2026-04-30.

What conditions does trial NCT04506151 study?

This clinical trial studies the following conditions: Type 1 Diabetes.

What interventions are being tested in trial NCT04506151?

The interventions under investigation include: Healthy Living (BEHAVIORAL), Sleep-Opt (BEHAVIORAL).

Who is sponsoring clinical trial NCT04506151?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04506151 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.